In line with these experimental findings, several cross-sectional and prospective epidemiologic studies have associated low IGFBP-1 levels with obesity [84], high fasting insulin [75], impaired glucose tolerance, and diabetes [75,76,85] in middle-aged individuals. Here, IGFBP1 is linked to obesity due to melanocortin 4 receptor deficiency.